{"slideshow_credits": null, "snippet": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition....", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2016/11/05/business/dealbook/competition-would-be-the-best-solution-to-rising-drug-prices.html", "lead_paragraph": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition.", "headline": {"main": "Competition Would Be the Best Solution to Rising Drug Prices", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "581ce12c7c459f6a5fccc51a", "word_count": "393", "multimedia": [], "pub_date": "2016-11-04T19:27:29Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Antitrust Laws and Competition Issues", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}